You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 7,981,445

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,981,445

Title:	Compositions and methods for preparation of poorly water soluble drugs with increased stability
Abstract:	The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
Inventor(s):	De; Tapas (Los Angeles, CA), Desai; Neil P. (Los Angeles, CA), Yang; Andrew (Rosemead, CA), Yim; Zachary (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA)
Assignee:	Abraxis Bioscience, LLC (Los Angeles, CA)
Application Number:	12/402,358
Patent Claims:	1. A composition comprising 1) nanoparticles comprising docetaxel coated with a carrier protein, wherein said carrier protein is albumin and 2) a citrate selected from the group consisting of citric acid and sodium citrate, wherein stability of the composition is enhanced as compared to that of a composition without citric acid or sodium citrate. 2. The composition according to claim 1, wherein the ratio of albumin to docetaxel is about 18:1 or less. 3. The composition according to claim 1, wherein the nanoparticles in the composition have an average or mean particle size of no greater than about 200 nm. 4. The composition according to claim 1, wherein the composition is a liquid suspension of docetaxel at a concentration of at least about 1 mg/ml. 5. The composition according to claim 1, wherein the composition is a dry composition that can be reconstituted to a liquid suspension with at least about 1 mg/ml docetaxel. 6. The composition according to claim 1, wherein the composition further comprises sodium chloride. 7. The composition according to claim 6, wherein the composition comprises about 200 mM sodium citrate and about 300 mM sodium chloride. 8. The composition according to claim 1, wherein the albumin is human serum albumin. 9. The composition according to claim 1, wherein the citrate is sodium citrate. 10. The composition according to claim 1, wherein the pH of the composition is no less than about 6. 11. The composition according to claim 1, wherein the composition is stable for at least about 24 hours following reconstitution or rehydration. 12. The composition according to claim 8, wherein the composition further comprises sodium chloride. 13. The composition according to claim 8, wherein the citrate is sodium citrate. 14. The composition according to claim 13, further comprising sodium chloride.

Details for Patent 7,981,445

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Grifols Therapeutics Llc	ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5	albumin (human)	For Injection	101138	10/21/1942	⤷ Try a Trial	2025-08-31
Baxalta Us Inc.	BUMINATE, FLEXBUMIN	albumin (human)	Injection	101452	03/03/1954	⤷ Try a Trial	2025-08-31
Csl Behring Ag	ALBURX	albumin (human)	Injection	102366	07/23/1976	⤷ Try a Trial	2025-08-31
Grifols Biologicals Llc	ALBUTEIN	albumin (human)	Injection	102478	08/15/1978	⤷ Try a Trial	2025-08-31
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.